X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INTERNATIONAL JOURNAL OF CANCER

期刊標題檢索 INT J CANCER 最新評論: Submitted on August 25, 2024, it was under review the next day. Aft... (2024-11-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INTERNATIONAL JOURNAL OF CANCER]您好,您是該頁面的第 191629 位訪客。

期刊簡介
期刊名稱INTERNATIONAL JOURNAL OF CANCER INTERNATIONAL JOURNAL OF CANCER
LetPub Score
8.0
50 ratings
Rate

Reputation
8.8

Influence
7.1

Speed
9.1

期刊簡稱INT J CANCER
ISSN0020-7136
E-ISSN1097-0215
h-index212
CiteScore
CiteScoreSJRSNIPCiteScore Rank
13.402.1311.670
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q138 / 404
Category: Medicine
Subcategory: Cancer Research
Q132 / 230

自引率 (2023-2024)1.80%自引率趨勢
掲載範囲
The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:

-Cancer Epidemiology-
Cancer Genetics and Epigenetics-
Infectious Causes of Cancer-
Innovative Tools and Methods-
Molecular Cancer Biology-
Tumor Immunology and Microenvironment-
Tumor Markers and Signatures-
Cancer Therapy and Prevention
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215
在線稿件提交http://mc.manuscriptcentral.com/ijc-wiley
開放訪問No
出版商Wiley-Liss Inc.
主題領域医学
出版國/地區SWITZERLAND
發行頻率月2回刊行
創刊年0
每年文章數355每年文章數趨勢
黃金OA百分比39.88%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ154/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0020-7136%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.5 Month(s)
競爭力 *來自作者的數據: About 28%
參考鏈接
相關期刊 【INTERNATIONAL JOURNAL OF CANCER】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330978
    CANCER RESEARCH312133
    BMC CANCER245502
    Asian Pacific Journal of Cancer Prevention219205
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    CLINICAL CANCER RESEARCH181666
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176416
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
    CANCER148385
  •  

    INTERNATIONAL JOURNAL OF CANCER INTERNATIONAL JOURNAL OF CANCER
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/23)
  [INTERNATIONAL JOURNAL OF CANCER] 的評論撰寫評論
作者: FFFF_X


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-11-06 15:02:29 評論於
Submitted on August 25, 2024, it was under review the next day. After waiting for two and a half months, I received a rejection letter. One of the reviewers was very good and provided many helpful and constructive comments. Sigh, I can only blame my own article for being too rubbish.
(0) 讚! | FFFF_X

作者: ljxccc


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-16 13:05:37 評論於
10-13 submitted, 10-16 Under review... Oh no, does that mean it's being sent for external review?
(0) 讚! | ljxccc

作者: 蕴美mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 16:47:24 評論於
Is contacting the editor to introduce your article content? Is it similar to sending a cover letter to them?
(0) 讚! | 蕴美mm

作者: 北国兴运


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-26 08:33:37 評論於
How did it turn out?
(0) 讚! | 北国兴运

作者: Stan Chaucer


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 10:24:45 評論於
Can I ask if UR has been audited? I was under evaluation for a few days first, then it was UR, and then UR again.
(0) 讚! | Stan Chaucer

作者: Ferdinand Lattimore


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-24 23:01:17 評論於
Can I ask if you need a whole body MRI with contrast and three repetitions?
(0) 讚! | Ferdinand Lattimore

作者: 北海巧丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-07 14:53:55 評論於
Are you interested in clinical oncology? This magazine.
(0) 讚! | 北海巧丽

作者: Augus Fowler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-26 17:56:46 評論於
How are you doing now? Isn't it easy to accept the summary of the commissioning?
(0) 讚! | Augus Fowler

作者: 魔都彩萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-26 09:36:01 評論於
Hello, may I ask if WB original data needs to be tripled?
(0) 讚! | 魔都彩萱

作者: 蓬莱山付娟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 21:49:52 評論於
Under evaluation
(0) 讚! | 蓬莱山付娟

作者: 蓬莱山付娟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 19:23:23 評論於
Submitted 3 times, the first time it returned for review in 18 days, during which the original data needed to be experimented upon, the second time it was under consideration and then rejected in 5 days. The third time it returned for review in 3 months, during which it was initially under consideration. 9 days later, the format was requested to be changed and the original experimental data to be uploaded before it was sent for review
(0) 讚! | 蓬莱山付娟

作者: 柔丽三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-22 12:18:41 評論於
I would like to ask what's going on. It has been a week since I submitted it and it still shows under evaluation
(0) 讚! | 柔丽三岁啦

作者: 晨风杉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-01 09:00:05 評論於
Please provide an update, it has been under evaluation for a week
(0) 讚! | 晨风杉月

作者: Cathy Rockefeller


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 21:41:29 評論於
How is your brother doing now?
(0) 讚! | Cathy Rockefeller

作者: Cathy Rockefeller


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 20:06:25 評論於
Does this mean it has been rejected, and will be changed to "awaiting decision"?
(0) 讚! | Cathy Rockefeller

作者: Cathy Rockefeller


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 17:57:52 評論於
How is your brother doing now?
(0) 讚! | Cathy Rockefeller

作者: 北风小玲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-22 13:20:47 評論於
How can cell line authentication be done?
(0) 讚! | 北风小玲

作者: 水月子武


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 20:21:30 評論於
How are you doing now?
(0) 讚! | 水月子武

作者: 水月子武


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 12:55:53 評論於
Please synchronize progress
(0) 讚! | 水月子武

作者: 舒扬mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-06 10:31:02 評論於
Can I follow up on my application under evaluation for 12 days? I need to graduate urgently
(0) 讚! | 舒扬mio

作者: 奉天孤真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-27 12:14:57 評論於
Focused research direction: DNA damage repair
Sharing of experiences: I would like to ask everyone how their comprehensive review results are going. This is not a commissioned work. I have currently reviewed it and will provide quite a few opinions. Will it be a direct rejection or will there be more feedback? Thank you
(0) 讚! | 奉天孤真

作者: Oliver Macadam


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 23:17:53 評論於
Do I need to upload the original data of Weibo when submitting an article?
(0) 讚! | Oliver Macadam

作者: 半月小蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 20:02:56 評論於
How to resolve the issue of cell line authentication
(0) 讚! | 半月小蕊

作者: Tracy Stilwell


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-08 13:56:27 評論於
Do you need the raw data for the three repeated experiments?
(0) 讚! | Tracy Stilwell

作者: 魔都映柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 15:23:20 評論於
It has been 14 days since my current status, still under evaluation, I don't know what to do
(0) 讚! | 魔都映柏

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/23)

開始撰寫 [INTERNATIONAL JOURNAL OF CANCER] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*